Title of the register

Reference Center for Prion Diseases in Poland

Name of Principal Investigator
First nameBeata
Last nameSikorska
Address of institution where award is held
InstitutionMedical University of Lodz
Street AddressCzechoslowacka 8/10
  • Poland
  • Website


    Contact email
    1. Conditions included, or expected to be included, in the disease register
  • Prion disease
  • 2a. Stated aim of the cohort

    Surveillance of human prion diseases in Poland

    2b. Features distinguishing this register from other disease registers

    This is the only center for prion diseases in Poland

    3a. i) Number of publications that involve use of register to date
    3c. Information (i.e. research findings) expected to be gained from the register

    The number of cases is still low and the conclusions need to be verified on a higher number of cases

    4a. Study criteria: age range of participants
    Age in years from:50
    To (‘until death’ is applicable):until death
    4b. Study criteria: inclusion criteria

    Cases fulfilling criteria for probable or possible prion disease

    4c. Study criteria: exclusion criteria

    No clinical evidence for CJD

    5. Size of the register (i.e. number of patients enrolled)
  • 0 – 500 clinical cases
  • 6a. Measures used to characterise participants

    Age, sex, clinical symptoms at onset, MRI if available

    6b. Are there defined primary and secondary endpoints (e.g. defined health parameters)
  • No
  • 7a. i) Is the register of fixed duration


    7a. ii) Data collection start date


    7b. Stage of data collection/analysis for the register
  • Data collection ongoing
  • Data analysis ongoing
  • 8. Funding of the register
    How the register is fundedNo dedicated funding. Some means from governmental grants for research projects on prion diseases
    9. Data sweeping
    Number of data sweeps that have taken place0
    10.The clinical (phenotypic) information held in the register from patients and other participants such as family members is
  • Routinely collected as medical records
  • 11. Limit on the number of studies that can be based on this set of patients
  • No
  • 12a. Data stored in a database
    Yes/No% available
    12b. Data held as individual records
    Yes/No% available
    13a. Are data available to other groups


    13b. Access policy/mechanisms for access if data are available to other groups
  • Apply to PI or co-ordinator at resource
  • Applicant needs to provide separate external ethics approval
  • 14. Data sharing policy specified as a condition of use
  • No policy exists
  • 15a. Are tissues/samples/DNA available to other groups


    15b. i) Description of available tissues/samples/DNA
  • Living donors:blood
  • Living donors: cerebro-spinal fluid
  • Post-mortem donors: brain
  • 15b. ii) Form available tissues/samples/DNA are supplied in
  • Primary Samples: Stabilised samples (frozen or fixed)
  • 15b iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data


    16a. Is information on biological characteristics available to other group
  • No
  • 16b. Is the access policy/mechanism for obtaining details of the characteristics the same as that for obtaining other data


      Types: N/A
      Member States: N/A
      Diseases: N/A
      Years: N/A
      Database Categories: N/A
      Database Tags: N/A

      Export as PDF